Enfermedades retinianas y nuevas terapias
University of California, San Francisco
San Francisco, Estados UnidosPublicaciones en colaboración con investigadores/as de University of California, San Francisco (11)
2020
-
Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis
Scientific Reports, Vol. 10, Núm. 1
2019
-
Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia
Scientific Reports, Vol. 9, Núm. 1
-
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
Nature Medicine, Vol. 25, Núm. 1, pp. 152-164
2018
-
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers
Brain, Vol. 141, Núm. 10, pp. 2895-2907
-
CXCR4 involvement in neurodegenerative diseases
Translational Psychiatry, Vol. 8, Núm. 1
-
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677
-
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies
PLoS Medicine, Vol. 15, Núm. 1
2017
-
Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 88, Núm. 2, pp. 152-164
-
Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
Scientific Reports, Vol. 7, Núm. 1
2014
-
Frontotemporal dementia and its subtypes: A genome-wide association study
The Lancet Neurology, Vol. 13, Núm. 7, pp. 686-699